Rituximab and other emerging monoclonal antibody therapies for lymphoma

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.7, Iss.2, 2002-10, pp. : 289-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 1, 2000-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Improving monoclonal antibody therapies in cancer

Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The clinical application of monoclonal antibody therapies in renal transplantation

By Dhanireddy Kiran K Xu He Mannon Roslyn B Hale Douglas A Kirk Allan D

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 23-37

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma

Current Drug Discovery Technologies, Vol. 3, Iss. 4, 2006-12 ,pp. : 231-243

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm

By Wong Eric T

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1107-1114

Informa Healthcare

Access to resources Recommend Favorite